Beyond BCG: the potential for a more effective TB vaccine
- 1 November 1999
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 5 (11) , 487-492
- https://doi.org/10.1016/s1357-4310(99)01594-4
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AI-75320)
This publication has 35 references indexed in Scilit:
- A Cocktail ofMycobacterium bovisBCG Recombinants Expressing the SIV Nef, Env, and Gag Antigens Induces Antibody and Cytotoxic Responses in Mice Vaccinated by Different Mucosal RoutesAIDS Research and Human Retroviruses, 1998
- Assessment of worldwide tuberculosis controlThe Lancet, 1997
- BCG vaccination against tuberculosis: past disappointments and future hopesTrends in Microbiology, 1995
- BCG as a Vector for the Construction of Multivalent Recombinant VaccinesBiologicals, 1995
- BCG—mass or selective vaccination?Journal of Hospital Infection, 1995
- An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.The Journal of Experimental Medicine, 1993
- Disseminated tuberculosis in interferon gamma gene-disrupted mice.The Journal of Experimental Medicine, 1993
- Tuberculosis: Commentary on a Reemergent KillerScience, 1992
- Development of a BCG Recombinant Vehicle for Candidate AIDS VaccinesInternational Reviews of Immunology, 1990
- What is BCG?Tubercle, 1983